Search Results

You are looking at 1 - 4 of 4 items for :

  • "diabetic peripheral neuropathy" x
  • All content x
Clear All
Free access

Ji Chen, Chao Li, Wenjie Liu, Bin Yan, Xiaoling Hu, and Fengrui Yang

normalized to GAPDH determined by Western blot analysis after delivery of miR-155 inhibitor, miR-155 mimic or NRF2; * P  < 0.05 vs blank group. Cell experiments were repeated three times. DPN, diabetic peripheral neuropathy; GAPDH, glyceraldehyde-3-phosphate

Free access

Pabitra B Pal, Himangshu Sonowal, Kirtikar Shukla, Satish K Srivastava, and Kota V Ramana

Litchy WJ Tesfaye S Price KL Bastyr EJ 3rd & MBBQ Study Group 2005 Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double

Free access

Sehee Kim, Chanyang Kim, and Seungjoon Park

– 481 . ( doi:10.1007/BF02256096 ) Srinivasan S Stevens M Wiley JW 2000 Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction . Diabetes 49 1932 – 1938 . ( doi:10.2337/diabetes.49

Restricted access

Kiara Boodhoo, Mare Vlok, David L Tabb, Kathryn H Myburgh, and Mari van de Vyver

mRNAs expression profiling associated with diabetic peripheral neuropathy in rats . Journal of Cellular Biochemistry 120 15347 – 15359 . ( https://doi.org/10.1002/jcb.28802 ) Hase K Kanda A Hirose I Noda K Ishida S 2017 Systemic